182400 — NKGen Biotech Korea Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for NKGen Biotech Korea Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS/A	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	—	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20,760	15,018	653	5,176	2,759
Net Total Accounts Receivable
Net Total Receivables	4,117	3,675	5,245	1,915	1,542
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29,838	24,903	8,840	10,127	6,635
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	32,842	30,738	36.6	12.1	6,127
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	180,601	169,695	54,329	22,879	14,294
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	42,669	71,193	59,804	47,697	3,154
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	60,338	83,775	63,433	47,884	7,199
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	120,262	85,920	-9,104	-25,005	7,095
Total Liabilities & Shareholders' Equity	180,601	169,695	54,329	22,879	14,294
Total Common Shares Outstanding
Total Preferred Shares Outstanding